tiprankstipranks
Achilles Therapeutics (ACHL)
NASDAQ:ACHL
US Market

Achilles Therapeutics (ACHL) Income Statement

Compare
133 Followers

Achilles Therapeutics Income Statement

Last quarter (Q2 2024), Achilles Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Achilles Therapeutics's net income was $-16.38M. See Achilles Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -4.73M$ -3.69M$ -3.29M$ -778.00K$ -303.25K
Operating Expenses
$ 75.25M$ 78.38M$ 64.19M$ 33.73M$ 13.78M
Depreciation and Amortization
$ 4.73M$ 3.69M$ 3.29M$ 778.00K$ 303.25K
EBITDA
$ -70.44M$ -78.38M$ -57.77M$ -32.95M$ -13.47M
Operating Income
$ -75.25M$ -78.38M$ -64.19M$ -33.73M$ -13.78M
Other Income/Expenses
$ 6.08M$ 7.32M$ 3.13M$ 531.00K$ -215.00K
Pretax Income
$ -69.17M$ -71.06M$ -61.06M$ -33.20M$ -13.99M
Net Income
$ -69.67M$ -71.18M$ -61.10M$ -33.20M$ -13.99M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.74$ -1.82$ -2.13$ -0.82$ -8.52
Diluted EPS
$ -1.74$ -1.82$ -2.13$ -0.82$ -8.52
Weighted Average Shares Outstanding
39.97M 39.14M 28.65M 40.62M 1.64M
Weighted Average Shares Outstanding (Diluted)
39.97M 39.14M 28.65M 40.62M 1.64M
Currency in USD

Achilles Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis